Financials
| H1 2024 Results - Continued Performance & Growth | Sep. 17, 2024 |
| Revenue growth of 24% in H1 with 55% now recurring | Jul. 23, 2024 |
| Revenue growth of 22% & order book growth of 57% | May. 21, 2024 |
| Diaceutics PLC – Trading Update | Jan. 30, 2024 |
| Diaceutics PLC – Half Year Results | Sep. 26, 2023 |
| Final Results | Apr. 17, 2023 |
| Half-year Report | Sep. 27, 2022 |
Proxies
| Result of AGM | Jun. 24, 2024 |
| Notice of AGM and Posting of Annual Report | May. 29, 2024 |
| Results of Annual General Meeting | May. 18, 2023 |
| Notice of AGM and Posting of Annual Report | Apr. 25, 2023 |
| Result of AGM | May. 26, 2022 |
| Notice of AGM and Posting of Annual Report | Apr. 28, 2022 |
| Result of AGM | May. 19, 2021 |
Ownership Update
| Holding(s) in Company | Nov. 04, 2024 |
| PDMR Shareholding/Share Incentive Plan | Oct. 30, 2024 |
| Issue of Share Options/PDMR Shareholdings | Oct. 25, 2024 |
| Holding(s) in Company | Oct. 07, 2024 |
| PDMR Shareholding/Share Incentive Plan | Oct. 02, 2024 |
| PDMR Shareholding/SIP and TVR | Jul. 29, 2024 |
| Issue of Share Options/PDMR Shareholdings | Jul. 29, 2024 |
Announcements
| Awarded UK Research Institute Grant Funding of £1m | Dec. 05, 2024 |
| Total Voting Rights | Dec. 03, 2024 |
| Expansion of US Commercial Activities | Nov. 28, 2024 |
| Capital Markets Webinar | Nov. 05, 2024 |
| Board Change Update | Oct. 29, 2024 |
| Cancellation of Share Premium Account | Oct. 24, 2024 |
| Diaceutics Announces Key Leadership Appointment | Oct. 15, 2024 |